Jardiance Tablet (Empagliflozin)

Buy Jardiance Tablet (Empagliflozin), Empagliflozin is a medication commonly marketed under the brand name Jardiance. It is an oral antidiabetic drug that falls under the class of sodium-glucose cotransporter-2 (SGLT2) inhibitors.

Read More

Jardiance 10 Tablet (Empagliflozin 10mg)

Package QTY Price Add To Cart
30 Tablet/s $38.00
60 Tablet/s $74.00
90 Tablet/s $108.00

Jardiance 25 Tablet (Empagliflozin 25mg)

Package QTY Price Add To Cart
30 Tablet/s $45.00
60 Tablet/s $88.00
90 Tablet/s $128.00

Introduction of Jardiance Tablet (Empagliflozin)

Empagliflozin is a medication commonly marketed under the brand name Jardiance. It is an oral antidiabetic drug that falls under the class of sodium-glucose cotransporter-2 (SGLT2) inhibitors. Empagliflozin is primarily prescribed for the management of type 2 diabetes mellitus, a chronic metabolic disorder characterized by high blood sugar levels resulting from insulin resistance and inadequate insulin production. Empagliflozin tablet is an oral medication commonly prescribed under the brand name Jardiance for managing Type 2 Diabetes. It belongs to the class of SGLT2 inhibitors and works by promoting the excretion of excess glucose through urine, helping to lower blood sugar levels. It offers benefits in terms of cardiovascular and kidney protection and may also contribute to modest weight loss. This medication works by inhibiting the reabsorption of glucose in the kidneys, thereby promoting the excretion of excess glucose through urine, leading to a reduction in blood sugar levels. 

Empagliflozin Dosage Information:

Standard Dosage:

The usual recommended starting dose of Empagliflozin Tablet is 10 mg once daily. It can be taken with or without food and should be swallowed whole with a glass of water. The dosage can be adjusted based on individual response and tolerability.

Missed Dose:

If a dose is missed, it should be taken as soon as remembered, unless it is close to the time for the next scheduled dose. In such cases, the missed dose should be skipped, and the regular dosing schedule should be resumed. Double doses should not be taken to make up for a missed dose.


In case of an overdose, medical attention should be sought immediately. Symptoms of an overdose may include severe dehydration, excessive thirst, confusion, dizziness, and unusually high levels of blood sugar. Treatment typically involves supportive care to manage symptoms and restore electrolyte balance. 

Empagliflozin and SGLT2 Inhibitors:

Empagliflozin is a member of the SGLT2 inhibitors class, which stands for sodium-glucose cotransporter-2 inhibitors. This drug class addresses diabetes by reducing glucose reabsorption in the kidneys, allowing excess glucose to be eliminated through urine. SGLT2 inhibitors like Empagliflozin not only assist in diabetes management but have also shown positive effects on cardiovascular outcomes and kidney protection.

Empagliflozin Price:

Find the Empagliflozin price at our website 1mgstore.com, where we offer competitive pricing and a convenient platform to purchase your medications online. By providing transparent pricing and easy access, we aim to support individuals in managing their healthcare needs effectively.

Write Your Own Review
You're reviewing:Jardiance Tablet (Empagliflozin)
Your Rating

Some of the precautionary measures to be taken while using Jardiance Tablet (Empagliflozin)

  • Hypersensitivity: Individuals with a known hypersensitivity to Empagliflozin should avoid its use.
  • Renal Impairment: Dosing adjustments may be necessary in patients with moderate to severe renal impairment or end-stage renal disease.
  • Volume Depletion: Patients who are at an increased risk of volume depletion, such as those taking diuretics or with a history of low blood pressure, should use Empagliflozin cautiously.
  • Ketoacidosis Risk: Patients with a history of ketoacidosis or those consuming a low-carbohydrate diet should be closely monitored, as there is a potential risk of developing ketoacidosis.
  • Surgery and Illness: During periods of surgery or illness, Empagliflozin may need to be temporarily discontinued due to the increased risk of dehydration and ketone production.

Key Functions Must Be Noticed of Jardiance Tablet (Empagliflozin)

  • Diabetes Management: Empagliflozin is primarily used to manage type 2 diabetes mellitus. It helps lower blood sugar levels by increasing the excretion of glucose through urine.
  • Cardiovascular Benefits: Studies have shown that Empagliflozin can also provide cardiovascular benefits by reducing the risk of cardiovascular events, such as heart attacks and strokes, in individuals with type 2 diabetes and established cardiovascular disease.
  • Kidney Protection: This medication has been found to offer renal protective effects, slowing the progression of diabetic kidney disease and reducing the risk of adverse kidney outcomes.
  • Weight Loss: Empagliflozin may lead to modest weight loss in individuals with Diabetes due to the excretion of excess calories in the form of glucose through urine.
  • Blood Pressure Control: It can help lower blood pressure in people with type 2 diabetes, contributing to overall cardiovascular risk reduction.

A few of the subsequent impacts stemming from Jardiance Tablet (Empagliflozin)

  • Genital Infections: Some individuals may experience genital yeast infections or urinary tract infections due to increased glucose levels in the urine, creating an environment conducive to bacterial and fungal growth.
  • Dehydration: Empagliflozin's mechanism of action can lead to increased urination and fluid loss, potentially causing dehydration. It is important to maintain adequate fluid intake while on this medication.
  • Hypotension: A drop in blood pressure, especially upon standing up, may occur. Patients should be cautious, especially if they have a history of low blood pressure.
  • Ketoacidosis: Although rare, there have been reports of ketoacidosis, a serious condition where the body produces high levels of blood acids called ketones. This is more commonly associated with type 1 diabetes.
  • Renal Impairment: In some cases, Empagliflozin could lead to a decline in kidney function. Monitoring kidney function regularly is important, especially in patients with pre-existing kidney issues.

Frequently Asked Queries About Empagliflozin Tablet (Jardiance):

Q1. Can I take Empagliflozin Medication even if I don't have diabetes?

No, Empagliflozin is specifically indicated for individuals with type 2 diabetes. It works by targeting mechanisms relevant to diabetes management and might not provide any benefits for those without the condition.

Q2. Is weight loss a common side effect of Empagliflozin?

Yes, Empagliflozin can lead to modest weight loss in people with diabetes. This is due to the elimination of excess calories in the form of glucose through urine, along with its mechanism of action.

Q3. Can I continue taking Empagliflozin if I plan to undergo surgery?

It's recommended to consult your healthcare provider if you're planning surgery. In some cases, Empagliflozin might need to be temporarily stopped to prevent risks associated with dehydration and changes in ketone levels during the surgical period.

Q4. Are there any dietary restrictions while using Empagliflozin?

There are no specific dietary restrictions, but maintaining a balanced diet is important. People following low-carbohydrate diets should be cautious, as there's a potential risk of ketoacidosis due to increased ketone production.

Q5. Can Empagliflozin replace insulin in diabetes management?

Empagliflozin isn't a substitute for insulin. It's often used as an adjunct to other diabetes treatments. Your doctor will determine the most suitable treatment plan based on your individual needs, which might include insulin, oral medications, or a combination.

Significant Drug Interactions that Require Attention For Jardiance Tablet (Empagliflozin)

  • Diuretics: Concomitant use of Empagliflozin with diuretics may increase the risk of dehydration and hypotension.
  • Insulin and Hypoglycemic Agents: Combining Empagliflozin with insulin or other hypoglycemic agents may increase the risk of hypoglycemia. Dosage adjustments might be necessary.
  • CYP Enzyme Inhibitors: Drugs that inhibit certain enzymes (CYP2C9 and CYP3A4) may affect the metabolism of Empagliflozin, potentially altering its effectiveness or safety profile.
  • Digoxin: Empagliflozin could affect the levels of digoxin in the blood, requiring monitoring and potential dosage adjustments.
  • Rifampin: Rifampin, an antibiotic, may reduce the effectiveness of Empagliflozin. Close monitoring of blood sugar levels is recommended if these drugs are used together.
More Information Demo
Manufacturer : Boehringer Ingelheim
Equivalent Brand : Jardiance
Generic Search : Empagliflozin